Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.178NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.178NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.208NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.208NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.208NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.197NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.197NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.197NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.491NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.491NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-2491.68Singapore
B.1.491NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.8 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.8 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.8 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.39.3 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.39.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.39.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.75.3 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.75.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.75.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CY.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CY.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FR.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBJ.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBJ.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CP.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.1.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used